ATM and head and neck squamous cell carcinoma: Additionally, the novel ATM inhibitor GSK635416A, in combination with olaparib, seems to effectively radiosensitize HNSCC cell lines, whereas GSK635416A as monotherapy effectively inhibits HR and is less cytotoxic to normal fibroblasts as compared to olaparib [244].